reviewer training march 16, 2017 -...

Meg Watson, MPH

Epidemiologist

Epidemiology and Applied Research Branch

FOA DP17-1701:National Program of Cancer

Registries

Reviewer TrainingMarch 16, 2017

and

Welcome Thank You!

http://2.bp.blogspot.com/-vmJiBQhq7PE/UHNrgv0Yv8I/AAAAAAAAEq8/JmNusVmgj8Y/s1600/Happy_Monkey.jpg

http://2.bp.blogspot.com/-vmJiBQhq7PE/UHNrgv0Yv8I/AAAAAAAAEq8/JmNusVmgj8Y/s1600/Happy_Monkey.jpg

RELIABLE TRUSTED SCIENTIFIC DCPC

Training Objectives

• Understand background and purpose of FOA

• Identify expected outcomes for the NPCR (Program 3)

• Identify strategies that applicants are expected to implement

• Understand criteria for evaluating applications

• Questions and Answers

Background


NPCR

• 1992 Cancer Registry Amendment Act, Public Law 102-515, authorized CDC to establish NPCR

• Worked with states to develop model legislation and regulations

• Cancer is a reportable disease • Collect data on all cancers diagnosed• Highly standardized data collection system


DP17-1701: NPCR Purpose

Support ongoing implementation of Surveillance Activities in

the National Program of Cancer Registries by enhancing

central cancer registry infrastructure to facilitate reporting and

collection of complete and timely cancer data.

• Ensure the availability of high quality and timely cancer data

• Promote use of data in decision making, program implementation

and evaluation

6


NPCR

Utility of NPCR

• Monitor cancer trends over time

• Show cancer patterns, identify high-risk groups

• Guide planning and evaluation of cancer control

programs

• Help set priorities for cancer prevention and control


NPCR Eligibility

8

• State Health Departments or Bona fide Agents

• District of Columbia and Pacific Island

Jurisdictions or Bona fide agents

• SEER-only funded states (UT, NM, IA, CT, and HI)


Two Components

9

NPCR Funds 2 Components in this FOA

Component 1

Core Central Cancer Surveillance Registry Operations

Component 2

Enhanced Registry Operations - Special Projects


NPCR Funding

10

The National Program of Cancer Registries

• Fund up to 55 applicants for Component 1

• Fund up to 9 applicants for Component 2

• Approximately $38 million per year is available for

Component 1

• Approximately $1.6 million per year is available for

Component 2


Program RequirementsNPCR Program Standards/Requirements:

• Legislative Authority• Administration/Operations• Data Collection, Content and Format• Electronic Data Exchange• Data Completeness/Timeliness/Quality• Linkages• Data Quality Assurance and Education• Data Use and Data Monitoring• Data Submission


Program Performance

• Last 5-year cycle funded 48 program• 45 states and DC• Pacific Island Jurisdiction ( 5 territories)• Puerto Rico

• NPCR provides coverage - 96% percent of US Population• In collaboration with NCI – 100% population coverage

• Approximately 1.2 million new invasive cancer cases submitted to CDC each year

• Approximately 17 million invasive cancer cases overall

RELIABLE TRUSTED SCIENTIFIC DCPC 13

Central Cancer Registries in the US by Federal Funding Source, 2012

Program Strategies and Activities


Overarching Goal

• Collection and dissemination of high-quality data on all reportable incident cancer cases in a timely manner for the purpose of public health cancer prevention and control.

• Improved and enhanced electronic reporting to central cancer registries.

15


Purpose of Component 2

Fund three pilot projects to identity the feasibility of, and barriers to, the collection of new information on cancer cases through cancer registries.

16


Long Term Outcomes• Increased survival for all cancers

• Decreased incidence, morbidity, and mortality for all

cancers

• Reduced cancer risk e.g. tobacco, alcohol, UV exposure

• Increased collaboration with Chronic Disease Programs

at state and local levels

18


CIN III Program Activities

For Component 2, CIN III award recipients:

Strategy 1: Program Collaboration• Collaborate with appropriate programs/partners to

facilitate successful implementation of project and use of the data for program planning, and evaluation.

19



Strategy 3: Cancer Data and Surveillance (Domain 3)

• Obtain/maintain the legal authority of CCR to collect data electronically on cervical cancer precursors from medical andpathology records

• Establish/improve infrastructure and partnerships, and develop a plan for CIN III data collection

• Implement CIN III project and collect enhanced data on cervical cancer precursors, using established data collection procedures,automated edits, quality control procedures and data submission specifications

20



21

• Link registry data with additional data sources, such as vaccine registry, cervical cancer screening data, comprehensive cancer control activities, or other relevant information.

• Submit CIN III data to CDC annually, in November of each year.


SCREENING Program Activities

Strategy 1: Program Collaboration

• Collaborate with NBCCEDP and other appropriate programs/partners to

facilitate successful implementation of project and use of the breast and

cervical cancer screening and diagnostic follow-up data for program

planning, and evaluation.


SCREENING Program ActivitiesStrategy 3: Cancer Data and Surveillance (Domain 3)

• Obtain/maintain the legal authority of CCR to collect screening and diagnostic follow-up data on women diagnosed with breast or cervical cancer.

• Establish/improve infrastructure and partnerships and develop a plan to electronically collect breast and cervical cancer screening and diagnostic follow-up data on women diagnosed with breast or cervical cancer.

• Establish data submission specifications, data collection procedures, automated edits, and quality control procedures in collaboration with NPCR and NBCCEDP award recipients or other partners in the catchment area.

• Implement project and collect breast and cervical cancer screening and diagnostic follow-up data.

23


SCREENING Program Activities

• Link registry data with other relevant data sources

• Submit breast and cervical cancer screening and diagnostic follow-up data to CDC annually, in November of each year.

• Evaluate data and utilize quality assurance findings to continuously improve breast and cervical cancer screening and diagnostic follow-up data.

• Disseminate breast and cervical cancer screening and diagnostic follow-up data and findings to key partners/stakeholders

24


Prognostic Factor Program Activities

Strategy 1: Program Collaboration

• Collaborate with CDC and other relevant partners to establish data submission specifications, data collection procedures, automated edits, and quality control procedures. (e.g., the American College of Surgeons-American Joint Committee on Cancer, College of American Pathologists, etc.)


Prognostic Factor Program ActivitiesStrategy 3: Cancer Data and Surveillance (Domain 3)

• Obtain/maintain the legal authority of CCR to collect the selected new/emerging prognostic factors on persons diagnosed with cancer in the state/territory/district.

• Establish/improve infrastructure and partnerships and develop a plan for prognostic factors data collection.

• Select new or emerging prognostic factors or risk assessment models recommended for clinical care in the American Joint Committee on Cancer (AJCC) Cancer Staging Manual, 8th Edition, and not collected prior to 2018 in any national cancer surveillance system

• Link registry data with other relevant data sources to improve quality and completeness of the prognostic factors.


Prognostic Factor Program Activities

Strategy 3: Cancer Data and Surveillance (Domain 3)

• Submit prognostic factor data to CDC annually, in November of each year.

• Evaluate data and utilize quality assurance findings to continuously improve prognostic factor data quality and completeness.

• Collaborate with appropriate programs and partners to facilitate successful implementation of project and use of the prognostic factor data for program planning, and evaluation.

• Disseminate prognostic factor data and findings to key partners and stakeholders to improve cancer care and reduce the cancer burden.

Application Review


Successful ApplicantsDemonstration of Adequate Staffing Capacity- Plan and ability to build upon current infrastructure or ability to hire quickly for the project. CVs, Bios, staffing plan/org chart

Readiness to meet project requirements and plan for long-term sustainability- Demonstrate prior experience implementing special projects - Legislative authority in place that supports innovative project

Experience and capability to perform the scope of work- Describe specific plans, mechanism to successfully implement the

special project;• CIN III project only: Document previous collection of cervical cancer precursor

data in at least one area of the state, or demonstrate the ability to quickly implement the project statewide without previous data collection experience.

29


Successful Applicants

Applicants may address requirements of the various sections in different places.

Please give applicant credit as long as information is provided.

30


Approach (25 points)

Applicants must present a coherent project description and work plan that aligns with NPCR logic model and describes an approach to collect enhanced data from one of the three Component 2 focus areas (CIN III, Screening, or Prognostic factors).

Project description should address the following:• Description of the approach and resources to be used in enhanced

data collection goals, including:- a staffing plan- an organizational chart - documentation of the percentage of time each staff


Approach(25 points)

• Work plan to establish or build upon infrastructure to collect enhanced data.

• Plan should describe process to establish data submission specifications, collection procedures, automated edits, and quality control procedures.

• Plan should describe inclusion of technical expertise from partners and collaborators.

• Timeline, including projected dates for milestones and completion by activity.


Evaluation and Performance Measurement(25 points)

1. Applicants must provide the following:

• Demonstration of previous successful collection of relevant data or organizational ability to collect such data (e.g. CIN III, screening data, or data on prognostic factors)

• Demonstration of collection of similar data or linkage with additional relevant data sources (may come from the entire population, or from an area or special research project)



2. Applicants must describe clear monitoring and evaluation procedures for:

• Evaluation of timeliness, quality, and completeness of enhanced data

• Submission of enhanced data in accordance with requested timeline (November of each year)

• Plan should describe strategies and activities to continuously improve data quality and completeness, including formal external audits of reporting facilities and processes and informal quality checks, as needed.



3. Applicants must detail capacity and intent to analyze, apply and disseminate cancer registry data, including:

• Plan to evaluate and disseminate enhanced data in order to improve state cancer control programs and to share information on feasibility of enhanced data collection;

• Plan to link registry data with enhanced data and additional sources, such as vaccine registry data, screening data, or other relevant information such as population-level disparities and areas of need (especially in the case of screening)

35


Organizational Capacity(50 points)

1. Describe infrastructure to meet or exceed collection of cancer data by central cancer registry:

• IT resources and support for electronic collection of enhanced registry data and linkages with relevant data

• Legal authority and policies to support collection and submission of enhanced cancer data in accordance with NPCR program standards and data release policy


Organizational Capacity(50 points)

2. Document prior success related to data collection, submission and application• Years which program has achieved NPCR National Data Quality and

Advanced National Data Quality standards for inclusion in US Cancer Statistics

• Activities and outcomes from partnerships and coalitions reports, publications, and presentation of data to public, policy makers, and partners (e.g., healthcare, academic, and non-profit organizations)

• Previous collection of data included in enhanced data collection (e.g. pre-invasive cervical cancers, screening or medical history studies, collection of additional biomarkers or other prognostic factors)


Budget(0 points)

• Does the submitted budget align with staffing and proposed project and work plan?

• Is an itemized budget narrative provided?

• Does awardee allocate no more than 20% of the total budget for registry software support (i.e. IT Support, Server, etc.) if relevant?

• Are Matching funds, Maintenance of Effort and Additional and in-kind funds provided in budget?


Additional Information

Important Sections of FOA:

E. Review and Selection Process (+- page 46-48 for Program 3)

b. Evaluation and Performance Measurement Section (+- page 26-27 for Program 3)

Additional Resources

DP17-1701 FOA Website:

https://www.cdc.gov/cancer/dcpc/about/foa-dp17-1701/

Thank You!

QUESTIONS?

https://www.google.com/url?sa=i&rct=j&q=&esrc=s&source=images&cd=&cad=rja&uact=8&ved=0ahUKEwi3-9D3nsfSAhXIRiYKHRy-D2QQjRwIBw&url=https://www.youtube.com/watch?v%3DQ4ZIKzRSc0s&psig=AFQjCNH_GRiRertleAnQabyIEcVzIiL9Zg&ust=1489073964281077

https://www.google.com/url?sa=i&rct=j&q=&esrc=s&source=images&cd=&cad=rja&uact=8&ved=0ahUKEwi3-9D3nsfSAhXIRiYKHRy-D2QQjRwIBw&url=https://www.youtube.com/watch?v%3DQ4ZIKzRSc0s&psig=AFQjCNH_GRiRertleAnQabyIEcVzIiL9Zg&ust=1489073964281077

Contact• For Reviewer Related Questions contact:

Jennifer WebberGrant Review Manager

CoE/ARM Services

Email: [email protected].

Phone: Phone:e703.248.2084

mailto:[email protected]

tel:(703)%20248-2084

The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

Go to the official source of cancer prevention information: www.cdc.gov/cancer.

@CDC_Cancer

CDC Breast Cancer

Follow DCPC

Online!

http://www.cdc.gov/cancer

reviewer training march 16, 2017 -...

Documents